サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1566949

血管封鎖用医療用接着剤市場：手技別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年

Vascular Sealing Medical Glue Market By Procedure (Revascularization, Others) , By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033

出版日
ページ情報
英文 280 Pages
納期
2～3営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
血管封鎖用医療用接着剤市場：手技別、エンドユーザー別：世界の機会分析と産業予測、2024年～2033年
出版日: 2024年07月10日
発行: Allied Market Research
ページ情報: 英文 280 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血管封鎖用医療用接着剤市場は、2023年に7億米ドルと評価され、2024年から2033年にかけてCAGR 7.3％で成長し、2033年には14億米ドルに達すると予測されています。

血管封鎖用医療用接着剤は、高い接着性と止血性を有する外科用接着剤であり、組織の封鎖と補強に使用されます。これらの接着剤は、損傷した組織間や組織と移植された生体材料との間に機能的な接続を作り出す上で極めて重要な役割を果たしています。このような接着剤は、従来の外科手術で有用であった外科的縫合や機械的な組織融合の方法を最小限にするために開発されました。これは、血管封鎖接着剤が組織の再生と治癒を促進し、感染のリスクを軽減し、従来の方法と比較して組織の外傷を最小限に抑えるという事実に起因しています。市場で入手可能な天然の医療用接着剤には、フィブリン接着剤やコラーゲンベースの製品があり、接着効果が高いです。

世界の血管封鎖用医療接着剤市場の成長は、心血管疾患の憂慮すべき有病率の上昇と、それに伴う血管形成術や冠動脈バイパス移植術などの手術の必要性の増加が、血管封鎖用医療接着剤の需要を押し上げていることが主な要因です。世界心臓連盟によると、心血管疾患は他のどの原因よりも世界の死亡原因の第一位です。毎年約2,050万人が心血管疾患が原因で死亡しています。このうち85％は冠動脈疾患（心臓発作など）と脳血管疾患（脳卒中など）によるものです。さらに、老人人口の増加が市場の成長に大きく寄与しています。これは、高齢者は心疾患に罹患しやすく、静脈瘤や動脈硬化などの問題に対処するための処置がしばしば必要となるため、血管封鎖用医療用接着剤の必要性が高まるという事実に起因しています。スペイン心臓病学会の公式出版物であるRevista Espanola de Cardiologiaが発表した論文によると、冠動脈性心疾患は65歳以上の成人の81％が死亡する主な原因となっています。さらに、回復時間の短縮や入院期間の短縮により、患者やヘルスケア提供者の間で低侵襲手技への嗜好が高まっていることも、市場の成長を促進しています。しかし、血管封鎖用医療用接着剤に関連する安全性への懸念が市場の成長を妨げています。例えば、一部の接着剤は細胞毒性があり、吸収が悪いため、ヘルスケア環境での需要が制限されます。さらに、医療用接着剤が適切かつ即時的な密閉を提供できないこと、感染リスクの増大、治癒の遅延が市場の主要な阻害要因として作用しています。逆に、手術部位の感染リスクを低減するため、メーカーは抗菌特性を持つ血管封鎖用医療用接着剤を開発しており、術後ケアと患者の安全を確保しています。さらに、接着強度を高めるための医療用接着剤の処方における継続的な技術革新は、予測期間中に市場拡大のための有利な機会を提供すると期待されています。

世界の血管封鎖用医療用接着剤市場は、手技、エンドユーザー、地域に区分されます。手技別では、市場は血行再建術とその他に分類されます。エンドユーザー別では、病院、専門クリニック、外来手術センターに分けられます。地域別では、市場は北米、欧州、アジア太平洋、LAMEAで分析されます。

主な調査結果

  • 手技別では、血行再建術が2023年の市場シェアを独占しました。
  • エンドユーザー別では、病院セグメントが2023年に最も高い成長を示しました。
  • 地域別では、北米が2023年に市場をリードしたが、アジア太平洋が予測期間中に最も高いCAGRを記録すると予想されます。

本レポートのカスタマイズが可能です（追加費用とスケジュールが必要です。）

  • 規制ガイドライン
  • 顧客の関心に応じた企業プロファイルの追加
  • 国別または地域別の追加分析-市場規模と予測
  • 企業プロファイルの拡張リスト
  • 過去の市場データ
  • 主要プレーヤーの詳細（所在地、連絡先、サプライヤー／ベンダーネットワークなどを含む、エクセル形式）

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資機会
    • 主要成功戦略
  • ポーターのファイブフォース分析
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会

第4章 血管封鎖用医療用接着剤市場：手技別

  • 市場概要
  • 血行再建術
  • その他

第5章 血管封鎖用医療用接着剤市場：エンドユーザー別

  • 市場概要
  • 病院
  • 専門クリニック
  • 外来手術センター

第6章 血管封鎖用医療用接着剤市場：地域別

  • 市場概要
  • 北米
    • 主要市場動向と機会
    • 米国の血管封鎖用医療用接着剤市場
    • カナダの血管封鎖用医療用接着剤市場
    • メキシコの血管封鎖用医療用接着剤市場
  • 欧州
    • 主要市場動向と機会
    • ドイツの血管封鎖用医療用接着剤市場
    • フランスの血管封鎖用医療用接着剤市場
    • 英国の血管封鎖用医療用接着剤市場
    • イタリアの血管封鎖用医療用接着剤市場
    • スペインの血管封鎖用医療用接着剤市場
    • その他欧州の血管封鎖用医療用接着剤市場
  • アジア太平洋
    • 主要市場動向と機会
    • 日本の血管封鎖用医療用接着剤市場
    • 中国の血管封鎖用医療用接着剤市場
    • オーストラリアの血管封鎖用医療用接着剤市場
    • インドの血管封鎖用医療用接着剤市場
    • 韓国の血管封鎖用医療用接着剤市場
    • その他アジア太平洋の血管封鎖用医療用接着剤市場
  • ラテンアメリカ・中東・アフリカ
    • 主要市場動向と機会
    • ブラジルの血管封鎖用医療用接着剤市場
    • サウジアラビアの血管封鎖用医療用接着剤市場
    • 南アフリカの血管封鎖用医療用接着剤市場
    • その他のラテンアメリカ・中東・アフリカの血管封鎖用医療用接着剤市場

第7章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要企業のポジショニング（2023年）

第8章 企業プロファイル

  • Baxter International Inc.
  • Becton, Dickinson And Company
  • Artivion, Inc.
  • Success Bio-tech
  • Integra LifeSciences Holdings Corporation
  • Stryker Corporation
  • Abbott Laboratories
  • Terumo Corporation
  • Johnson And Johnson
  • Medtronic
目次
Product Code: A324057

The vascular sealing medical glue market was valued at $0.7 billion in 2023, and is projected to reach $1.4 billion by 2033, growing at a CAGR of 7.3% from 2024 to 2033.

Vascular sealing medical glue is a surgical adhesive that possesses high adhesive and hemostatic properties, and is used to seal and reinforce tissues. These adhesives are play a pivotal role in creating functional connections between damaged tissues and between tissues and implanted biomaterials. They are majorly developed to minimize the use of surgical sutures and mechanical methods of tissue fusion, which are useful in conventional surgeries. This is attributed to the fact that vascular sealing glues promote tissue regeneration and healing, mitigate the risk of infection, and minimize tissue trauma as compared to conventional methods. Natural medical adhesives available in the market include fibrin adhesives and collagen-based products, which are highly effective in adhesion.

The growth of the global vascular sealing medical glue market is majorly driven by alarming rise in prevalence of cardiovascular diseases and corresponding increase in need for surgeries, such as angioplasty and coronary artery bypass grafting, are boosting the demand for vascular sealing medical glue. According to the World Heart Federation, cardiovascular diseases are the leading cause of death worldwide as compared to any other cause. Approximately 20.5 million die every year due to cardiovascular diseases. Of these deaths, 85% are due to coronary heart diseases (e.g., heart attacks) and cerebrovascular diseases (e.g., strokes). Moreover, increase in geriatric population significantly contributes toward the growth of the market. This is attributed to the fact that aged individuals are highly susceptible to cardiac diseases and often require procedures to address issues such as varicose veins and atherosclerosis, thus increasing the need for vascular sealing glues. As per the article published by the Revista Espanola de Cardiologia-the official publication of the Spanish Society of Cardiology-coronary heart disease is the leading cause of death in 81% of adults aged 65 years or older. Furthermore, increase in preference for minimally invasive procedures among patients and healthcare providers due to quicker recovery times and reduced hospital stays fosters the growth of the market. However, safety concerns associated with vascular sealing medical glue hamper the growth of the market. For instance, some adhesives are cytotoxic and are poorly absorbed, which limit their demand in healthcare settings. Furthermore, inability to medical adhesives to provide adequate and immediate seal, increased risk of infection, and delayed healing act as the key deterrent factors of the market. On the contrary, to reduce the risk of infection at the surgical sites, manufacturers are developing vascular sealing medical glue with antimicrobial properties, thus ensuring post-operative care and patient safety. In addition, continuous innovations in the formulation of medical glues to enhance their adhesive strength are expected to offer lucrative opportunities for the expansion of the market during the forecast period.

The global vascular sealing medical glue market is segmented into procedure, end user, and region. By procedure, the market is categorized into revascularization and others. On the basis of end user, it is divided into hospitals, specialty clinics, and ambulatory surgical centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

  • By procedure, the revascularization segment dominated the market share in 2023.
  • On the basis of end user, the hospitals segment exhibited the highest growth in 2023.
  • Region wise, North America lead the market in 2023; however, Asia-Pacific is expected to register highest CAGR during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global vascular sealing medical glue market include Baxter International Inc., Becton, Dickinson and Company, Artivion, Inc., Success Bio-tech, Integra LifeSciences Holdings Corporation, Stryker Corporation, Abbott Laboratories, Terumo Corporation, Johnson & Johnson, and Medtronic. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Procedure

  • Revascularization
  • Others

By End User

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Baxter International Inc.
    • Becton, Dickinson and Company
    • Artivion, Inc.
    • Success Bio-tech
    • Integra LifeSciences Holdings Corporation
    • Stryker Corporation
    • Abbott Laboratories
    • Terumo Corporation
    • Johnson & Johnson
    • Medtronic

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: VASCULAR SEALING MEDICAL GLUE MARKET, BY PROCEDURE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Procedure
  • 4.2. Revascularization
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Others
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: VASCULAR SEALING MEDICAL GLUE MARKET, BY END USER

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By End User
  • 5.2. Hospitals
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Specialty Clinics
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Ambulatory Surgical Centers
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country

CHAPTER 6: VASCULAR SEALING MEDICAL GLUE MARKET, BY REGION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Region
  • 6.2. North America
    • 6.2.1. Key Market Trends and Opportunities
    • 6.2.2. Market Size and Forecast, By Procedure
    • 6.2.3. Market Size and Forecast, By End User
    • 6.2.4. Market Size and Forecast, By Country
    • 6.2.5. U.S. Vascular Sealing Medical Glue Market
      • 6.2.5.1. Market Size and Forecast, By Procedure
      • 6.2.5.2. Market Size and Forecast, By End User
    • 6.2.6. Canada Vascular Sealing Medical Glue Market
      • 6.2.6.1. Market Size and Forecast, By Procedure
      • 6.2.6.2. Market Size and Forecast, By End User
    • 6.2.7. Mexico Vascular Sealing Medical Glue Market
      • 6.2.7.1. Market Size and Forecast, By Procedure
      • 6.2.7.2. Market Size and Forecast, By End User
  • 6.3. Europe
    • 6.3.1. Key Market Trends and Opportunities
    • 6.3.2. Market Size and Forecast, By Procedure
    • 6.3.3. Market Size and Forecast, By End User
    • 6.3.4. Market Size and Forecast, By Country
    • 6.3.5. Germany Vascular Sealing Medical Glue Market
      • 6.3.5.1. Market Size and Forecast, By Procedure
      • 6.3.5.2. Market Size and Forecast, By End User
    • 6.3.6. France Vascular Sealing Medical Glue Market
      • 6.3.6.1. Market Size and Forecast, By Procedure
      • 6.3.6.2. Market Size and Forecast, By End User
    • 6.3.7. UK Vascular Sealing Medical Glue Market
      • 6.3.7.1. Market Size and Forecast, By Procedure
      • 6.3.7.2. Market Size and Forecast, By End User
    • 6.3.8. Italy Vascular Sealing Medical Glue Market
      • 6.3.8.1. Market Size and Forecast, By Procedure
      • 6.3.8.2. Market Size and Forecast, By End User
    • 6.3.9. Spain Vascular Sealing Medical Glue Market
      • 6.3.9.1. Market Size and Forecast, By Procedure
      • 6.3.9.2. Market Size and Forecast, By End User
    • 6.3.10. Rest of Europe Vascular Sealing Medical Glue Market
      • 6.3.10.1. Market Size and Forecast, By Procedure
      • 6.3.10.2. Market Size and Forecast, By End User
  • 6.4. Asia-Pacific
    • 6.4.1. Key Market Trends and Opportunities
    • 6.4.2. Market Size and Forecast, By Procedure
    • 6.4.3. Market Size and Forecast, By End User
    • 6.4.4. Market Size and Forecast, By Country
    • 6.4.5. Japan Vascular Sealing Medical Glue Market
      • 6.4.5.1. Market Size and Forecast, By Procedure
      • 6.4.5.2. Market Size and Forecast, By End User
    • 6.4.6. China Vascular Sealing Medical Glue Market
      • 6.4.6.1. Market Size and Forecast, By Procedure
      • 6.4.6.2. Market Size and Forecast, By End User
    • 6.4.7. Australia Vascular Sealing Medical Glue Market
      • 6.4.7.1. Market Size and Forecast, By Procedure
      • 6.4.7.2. Market Size and Forecast, By End User
    • 6.4.8. India Vascular Sealing Medical Glue Market
      • 6.4.8.1. Market Size and Forecast, By Procedure
      • 6.4.8.2. Market Size and Forecast, By End User
    • 6.4.9. South Korea Vascular Sealing Medical Glue Market
      • 6.4.9.1. Market Size and Forecast, By Procedure
      • 6.4.9.2. Market Size and Forecast, By End User
    • 6.4.10. Rest of Asia-Pacific Vascular Sealing Medical Glue Market
      • 6.4.10.1. Market Size and Forecast, By Procedure
      • 6.4.10.2. Market Size and Forecast, By End User
  • 6.5. LAMEA
    • 6.5.1. Key Market Trends and Opportunities
    • 6.5.2. Market Size and Forecast, By Procedure
    • 6.5.3. Market Size and Forecast, By End User
    • 6.5.4. Market Size and Forecast, By Country
    • 6.5.5. Brazil Vascular Sealing Medical Glue Market
      • 6.5.5.1. Market Size and Forecast, By Procedure
      • 6.5.5.2. Market Size and Forecast, By End User
    • 6.5.6. Saudi Arabia Vascular Sealing Medical Glue Market
      • 6.5.6.1. Market Size and Forecast, By Procedure
      • 6.5.6.2. Market Size and Forecast, By End User
    • 6.5.7. South Africa Vascular Sealing Medical Glue Market
      • 6.5.7.1. Market Size and Forecast, By Procedure
      • 6.5.7.2. Market Size and Forecast, By End User
    • 6.5.8. Rest of LAMEA Vascular Sealing Medical Glue Market
      • 6.5.8.1. Market Size and Forecast, By Procedure
      • 6.5.8.2. Market Size and Forecast, By End User

CHAPTER 7: COMPETITIVE LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top Winning Strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

  • 8.1. Baxter International Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Key Executives
    • 8.1.3. Company Snapshot
    • 8.1.4. Operating Business Segments
    • 8.1.5. Product Portfolio
    • 8.1.6. Business Performance
    • 8.1.7. Key Strategic Moves and Developments
  • 8.2. Becton, Dickinson And Company
    • 8.2.1. Company Overview
    • 8.2.2. Key Executives
    • 8.2.3. Company Snapshot
    • 8.2.4. Operating Business Segments
    • 8.2.5. Product Portfolio
    • 8.2.6. Business Performance
    • 8.2.7. Key Strategic Moves and Developments
  • 8.3. Artivion, Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Key Executives
    • 8.3.3. Company Snapshot
    • 8.3.4. Operating Business Segments
    • 8.3.5. Product Portfolio
    • 8.3.6. Business Performance
    • 8.3.7. Key Strategic Moves and Developments
  • 8.4. Success Bio-tech
    • 8.4.1. Company Overview
    • 8.4.2. Key Executives
    • 8.4.3. Company Snapshot
    • 8.4.4. Operating Business Segments
    • 8.4.5. Product Portfolio
    • 8.4.6. Business Performance
    • 8.4.7. Key Strategic Moves and Developments
  • 8.5. Integra LifeSciences Holdings Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Key Executives
    • 8.5.3. Company Snapshot
    • 8.5.4. Operating Business Segments
    • 8.5.5. Product Portfolio
    • 8.5.6. Business Performance
    • 8.5.7. Key Strategic Moves and Developments
  • 8.6. Stryker Corporation
    • 8.6.1. Company Overview
    • 8.6.2. Key Executives
    • 8.6.3. Company Snapshot
    • 8.6.4. Operating Business Segments
    • 8.6.5. Product Portfolio
    • 8.6.6. Business Performance
    • 8.6.7. Key Strategic Moves and Developments
  • 8.7. Abbott Laboratories
    • 8.7.1. Company Overview
    • 8.7.2. Key Executives
    • 8.7.3. Company Snapshot
    • 8.7.4. Operating Business Segments
    • 8.7.5. Product Portfolio
    • 8.7.6. Business Performance
    • 8.7.7. Key Strategic Moves and Developments
  • 8.8. Terumo Corporation
    • 8.8.1. Company Overview
    • 8.8.2. Key Executives
    • 8.8.3. Company Snapshot
    • 8.8.4. Operating Business Segments
    • 8.8.5. Product Portfolio
    • 8.8.6. Business Performance
    • 8.8.7. Key Strategic Moves and Developments
  • 8.9. Johnson And Johnson
    • 8.9.1. Company Overview
    • 8.9.2. Key Executives
    • 8.9.3. Company Snapshot
    • 8.9.4. Operating Business Segments
    • 8.9.5. Product Portfolio
    • 8.9.6. Business Performance
    • 8.9.7. Key Strategic Moves and Developments
  • 8.10. Medtronic
    • 8.10.1. Company Overview
    • 8.10.2. Key Executives
    • 8.10.3. Company Snapshot
    • 8.10.4. Operating Business Segments
    • 8.10.5. Product Portfolio
    • 8.10.6. Business Performance
    • 8.10.7. Key Strategic Moves and Developments